271 related articles for article (PubMed ID: 28892521)
1. A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma.
Ajorloo F; Vaezi M; Saadat A; Safaee SR; Gharib B; Ghanei M; Siadat SD; Vaziri F; Fateh A; Pazhouhandeh M; Vaziri B; Moazemi R; Mahboudi F; Rahimi Jamnani F
PLoS One; 2017; 12(9):e0183969. PubMed ID: 28892521
[TBL] [Abstract][Full Text] [Related]
2. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database.
Luo B; Gu YY; Wang XD; Chen G; Peng ZG
Pathol Res Pract; 2018 Nov; 214(11):1854-1867. PubMed ID: 30244948
[TBL] [Abstract][Full Text] [Related]
3. Identification of key genes and pathways associated with classical Hodgkin lymphoma by bioinformatics analysis.
Kuang Z; Guo L; Li X
Mol Med Rep; 2017 Oct; 16(4):4685-4693. PubMed ID: 28791394
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Pathogenic Mechanisms Underlying Single and Recurrent Venous Thromboembolism Based on Gene Expression Profiling.
Xu D; Xu R; He L; Xu T; Zhang Z; Han D; Du J
Ann Vasc Surg; 2016 Oct; 36():252-259. PubMed ID: 27423718
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics methods for identifying differentially expressed genes and signaling pathways in nano-silica stimulated macrophages.
Zhang L; Hao C; Li J; Qu Y; Bao L; Li Y; Yue Z; Zhang M; Yu X; Chen H; Zhang J; Wang D; Yao W
Tumour Biol; 2017 Jun; 39(6):1010428317709284. PubMed ID: 28653889
[TBL] [Abstract][Full Text] [Related]
6. Novel targeted therapeutic agents for the treatment of childhood, adolescent and young adult non-Hodgkin lymphoma.
Barth MJ; Minard-Colin V
Br J Haematol; 2019 Jun; 185(6):1111-1124. PubMed ID: 30701541
[TBL] [Abstract][Full Text] [Related]
7. Identification of key genes and crucial modules associated with coronary artery disease by bioinformatics analysis.
Zhang X; Cheng X; Liu H; Zheng C; Rao K; Fang Y; Zhou H; Xiong S
Int J Mol Med; 2014 Sep; 34(3):863-9. PubMed ID: 24969630
[TBL] [Abstract][Full Text] [Related]
8. Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.
Cha S; Lee J; Shin JY; Kim JY; Sim SH; Keam B; Kim TM; Kim DW; Heo DS; Lee SH; Kim JI
BMC Cancer; 2016 Feb; 16():170. PubMed ID: 26925973
[TBL] [Abstract][Full Text] [Related]
9. Potential biomarkers and latent pathways for vasculitis based on latent pathway identification analysis.
Zhou T; Zhang Y; Wu P; Sun Q; Guo Y; Yang Y
Int J Rheum Dis; 2014 Jul; 17(6):671-8. PubMed ID: 24867262
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the pharmacological mechanism of the Chinese formula huanglian-jie-du decoction in the treatment of ischemic stroke using a systems biology-based strategy.
Zhang YQ; Wang SS; Zhu WL; Ma Y; Zhang FB; Liang RX; Xu HY; Yang HJ
Acta Pharmacol Sin; 2015 Jun; 36(6):724-33. PubMed ID: 25937634
[TBL] [Abstract][Full Text] [Related]
11. Small Molecule Inhibitors in Chronic Lymphocytic Lymphoma and B Cell Non-Hodgkin Lymphoma.
Rosenthal A
Curr Hematol Malig Rep; 2017 Jun; 12(3):207-216. PubMed ID: 28439761
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatic analyses revealed underlying biological functions correlated with oxaliplatin responsiveness.
Klahan S; Huang CC; Chien SC; Wu MS; Wong HS; Huang CY; Chang WC; Wei PL
Tumour Biol; 2016 Jan; 37(1):583-90. PubMed ID: 26232912
[TBL] [Abstract][Full Text] [Related]
13. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Hu S; Liao Y; Chen L
Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
[TBL] [Abstract][Full Text] [Related]
14. Identification of key pathogenic genes of sepsis based on the Gene Expression Omnibus database.
Lu X; Xue L; Sun W; Ye J; Zhu Z; Mei H
Mol Med Rep; 2018 Feb; 17(2):3042-3054. PubMed ID: 29257295
[TBL] [Abstract][Full Text] [Related]
15. Changed expression and function of P-gp in peripheral blood CD56 + cells predicting chemoresistance in non-Hodgkin lymphoma patients.
Han L; Guo X; Bian H; Zhou Y; Li T; Yang J
Cancer Biomark; 2015; 15(3):289-97. PubMed ID: 25769453
[TBL] [Abstract][Full Text] [Related]
16. Genomic expression profiling and bioinformatics analysis on diabetic nephrology with ginsenoside Rg3.
Wang J; Cui C; Fu L; Xiao Z; Xie N; Liu Y; Yu L; Wang H; Luo B
Mol Med Rep; 2016 Aug; 14(2):1162-72. PubMed ID: 27279428
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.
Jazirehi AR; Bonavida B
Oncogene; 2005 Mar; 24(13):2121-43. PubMed ID: 15789036
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of ADAM12 contributes to accelerated cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphoma.
Yin H; Zhong F; Ouyang Y; Wang Q; Ding L; He S
Hematology; 2017 Oct; 22(9):527-535. PubMed ID: 28395594
[TBL] [Abstract][Full Text] [Related]
20. A systems biology approach for miRNA-mRNA expression patterns analysis in non-small cell lung cancer.
Najafi A; Tavallaei M; Hosseini SM
Cancer Biomark; 2016; 16(1):31-45. PubMed ID: 26484609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]